HORMONAL-THERAPY OF SEXUAL DISORDERS

Citation
B. Cordier et al., HORMONAL-THERAPY OF SEXUAL DISORDERS, Bulletin de l'Academie nationale de medecine, 180(3), 1996, pp. 599-610
Citations number
16
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00014079
Volume
180
Issue
3
Year of publication
1996
Pages
599 - 610
Database
ISI
SICI code
0001-4079(1996)180:3<599:HOSD>2.0.ZU;2-H
Abstract
Because of the limits of justice, our society turns itself towards the medical need and demands efficient treatments. Mutilating neuro-surge ry and treatment with estrogens have been used and then stopped. Medro xyprogestrone (MPA) and Cyproterone (CPA) acetate have been proved to be efficient in 80% of cases studied and published. However the therap eutic use of CPA is limited in France by three drawbacks : exclusive o ral route of administration, lack of available biological criteria as a control of good observance and lack of official indication. Therefor e the authors studied a GnRH analogue (triptoreline) which induces a r eversible hormonal castration and which is administered by I.M. route monthly, It was efficient in five out of six aggressive hypersexual pa tients. An ethical study is proposed afterwhich the authors call for a n evolution of the mentalities about this question.